OBIO - Orchestra BioMed Holdings, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$11.50
DETAILS
HIGH:
$13.00
LOW:
$10.00
MEDIAN:
$11.50
CONSENSUS:
$11.50
UPSIDE:
103.18%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 99.4% |
| EBIT Margin | -154.0% |
| EBITDA Margin | -153.0% |
| Operating Margin | -154.7% |
| Pretax Margin | -157.4% |
| Cont. Ops Margin | -157.4% |
| Net Margin | -157.4% |
| Bottom Line Margin | -158.2% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 6.45 |
| Quick Ratio | 6.43 |
| Solvency Ratio | -1.017 |
| Cash Ratio | 2.07 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-3.74
Peers avg: 32.0
|
| PEG Ratio | 0.11 |
| Forward PEG | 0.11 |
| Price/Book | 3.13 |
| Price/Sales | 5.92 |
| Price/FCF | -4.01 |
| Price/Op Cash Flow | -4.05 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.1389 |
| Debt/Equity | 0.2517 |
| Debt/Capital | 0.2011 |
| Long-Term Debt/Capital | 0.1838 |
| Financial Leverage | 1.81 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.46 |
| Operating Cash Flow Ratio | -2.926 |
| Operating Cash Flow/Sales | -146.2% |
| Free Cash Flow/Operating Cash Flow | 101.0% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -44.62 |
| Interest Coverage | -45.1280 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -3.07 |
| Capital Expenditure Coverage | -100.13 |
| Dividend + Capital Expenditure Coverage | -100.13 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.70 |
| EPS | -1.104 |
| Debt/Share | 0.3582 |
| Cash/Share | 2.23 |
| Book Value/Share | 1.33 |
| Tangible BV/Share | 1.33 |
| Equity/Share | 1.33 |
| Operating Cash Flow/Share | -1.025 |
| Capital Expenditure/Share | 0.010 |
| FCF/Share | -1.036 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 1.017 |
| Price/Fair Value | 3.13 |
| Debt/Market Cap | 0.0720 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -3.50 |